Rho V Activators
Rho V activators are chemical agents that specifically target and modulate the activity of Rho family GTPases, particularly Rho V, which is a subtype within this extensive group of signaling molecules. The Rho family GTPases, in general, are a family of small (~21 kDa) signaling G proteins, and they are a part of the Ras superfamily. The members of the Rho family are known to be involved in a variety of cellular functions, primarily through the regulation of the actin cytoskeleton. This regulation is critical for processes such as cell shape determination, cell migration, cell cycle progression, and the formation of cell junctions. Rho proteins cycle between an active GTP-bound state and an inactive GDP-bound state, with GTPase-activating proteins (GAPs) facilitating the hydrolysis of GTP to GDP, thus inactivating the Rho protein, and guanine nucleotide exchange factors (GEFs) promoting the exchange of GDP for GTP to activate the Rho protein. Rho V activators would, by definition, engage with the regulatory cycle of Rho V, tipping the balance towards its active form.
The specificity of Rho V activators implies a precise and refined action, modulating the Rho V without broadly affecting other Rho GTPases or other cellular GTPases, thereby allowing for the selective study of Rho V-mediated pathways. The design of such activators would require a deep understanding of the molecular structure and regulatory mechanisms of Rho V to ensure targeted activation. In a cellular context, these molecules would interact with the GEFs, GAPs, or with Rho V directly, potentially by binding to the GTPase domain and promoting the GTP-bound state. In addition to their regulatory role in the GTPase cycle, these activators might also affect the interaction between Rho V and its downstream effectors, thereby influencing the downstream signaling cascades initiated by the activated Rho V. The understanding of Rho V activators and their precise mode of action is of significant interest for elucidating the fundamental cellular processes governed by Rho V and for advancing the knowledge of the intricate web of cellular signaling.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Calpeptin | 117591-20-5 | sc-202516 sc-202516A | 10 mg 50 mg | $121.00 $456.00 | 28 | |
Calpeptin is a potent inhibitor of calpain, a family of calcium-dependent proteases. By inhibiting calpain, Calpeptin can reduce the cleavage and inactivation of RhoA, a close homologue of Rho V, thus potentially enhancing the functional activity of Rho V by maintaining its active state and promoting Rho-associated signaling pathways which are crucial for actin cytoskeleton organization and cellular motility. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a selective inhibitor of ROCK (Rho-associated protein kinase), which is a downstream effector of the Rho family GTPases, including Rho V. Inhibition of ROCK leads to a reduction in stress fiber formation and cellular contraction, which can result in the compensatory activation of Rho V to re-establish cytoskeletal integrity and cellular tension homeostasis. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
ML141 is a selective and potent inhibitor of Cdc42 GTPase, a member of the Rho family. Inhibition of Cdc42 may result in compensatory upregulation and activation of other Rho GTPases, including Rho V, to maintain cellular functions such as migration and polarity that are regulated by the Rho GTPase family. | ||||||
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $151.00 $609.00 | 75 | |
NSC23766 inhibits the activation of Rac1 by preventing its interaction with specific GEFs. This selective inhibition can lead to a compensatory increase in the activity of Rho V as the cell attempts to balance the activities of different Rho GTPases to regulate the actin cytoskeleton, cell shape, and motility. | ||||||
Lysophosphatidic Acid | 325465-93-8 | sc-201053 sc-201053A | 5 mg 25 mg | $98.00 $341.00 | 50 | |
LPA is a bioactive phospholipid that acts through its G protein-coupled receptors (GPCRs) to activate Rho GTPases, including Rho V. LPA binding to GPCRs stimulates the RhoGEF-mediated conversion of Rho V to its active GTP-bound state, thereby enhancing its downstream signaling pathways involved in cytoskeletal reorganization and cellular proliferation. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $29.00 $90.00 $339.00 | 12 | |
Statins, like Lovastatin, are known to inhibit HMG-CoA reductase, leading to reduced prenylation and membrane localization of small GTPases. However, this can result in a compensatory upregulation of unprenylated Rho V, enhancing its functional activity in the cytoplasm and potentially leading to increased influence on signaling pathways that regulate cell shape and motility. | ||||||